| UniProt ID | RBM4_HUMAN | |
|---|---|---|
| UniProt AC | Q9BWF3 | |
| Protein Name | RNA-binding protein 4 | |
| Gene Name | RBM4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 364 | |
| Subcellular Localization | Nucleus. Nucleus, nucleolus. Nucleus speckle. Cytoplasm. Cytoplasmic granule. Undergoes continuous nucleocytoplasmic shuttling. Upon nuclear import colocalizes with SR proteins in nuclear speckles. Arsenite stress-induced phosphorylation increases it | |
| Protein Description | RNA-binding factor involved in multiple aspects of cellular processes like alternative splicing of pre-mRNA and translation regulation. Modulates alternative 5'-splice site and exon selection. Acts as a muscle cell differentiation-promoting factor. Activates exon skipping of the PTB pre-mRNA during muscle cell differentiation. Antagonizes the activity of the splicing factor PTBP1 to modulate muscle cell-specific exon selection of alpha tropomyosin. Binds to intronic pyrimidine-rich sequence of the TPM1 and MAPT pre-mRNAs. Required for the translational activation of PER1 mRNA in response to circadian clock. Binds directly to the 3'-UTR of the PER1 mRNA. Exerts a suppressive activity on Cap-dependent translation via binding to CU-rich responsive elements within the 3'UTR of mRNAs, a process increased under stress conditions or during myocytes differentiation. Recruits EIF4A1 to stimulate IRES-dependent translation initiation in respons to cellular stress. Associates to internal ribosome entry segment (IRES) in target mRNA species under stress conditions. Plays a role for miRNA-guided RNA cleavage and translation suppression by promoting association of AGO2-containing miRNPs with their cognate target mRNAs. Associates with miRNAs during muscle cell differentiation. Binds preferentially to 5'-CGCGCG[GCA]-3' motif in vitro.. | |
| Protein Sequence | MVKLFIGNLPREATEQEIRSLFEQYGKVLECDIIKNYGFVHIEDKTAAEDAIRNLHHYKLHGVNINVEASKNKSKTSTKLHVGNISPTCTNKELRAKFEEYGPVIECDIVKDYAFVHMERAEDAVEAIRGLDNTEFQGKRMHVQLSTSRLRTAPGMGDQSGCYRCGKEGHWSKECPIDRSGRVADLTEQYNEQYGAVRTPYTMSYGDSLYYNNAYGALDAYYKRCRAARSYEAVAAAAASVYNYAEQTLSQLPQVQNTAMASHLTSTSLDPYDRHLLPTSGAAATAAAAAAAAAAVTAASTSYYGRDRSPLRRATAPVPTVGEGYGYGHESELSQASAAARNSLYDMARYEREQYADRARYSAF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Ubiquitination | -----MVKLFIGNLP -----CCEEEECCCC | 36.06 | 21890473 | |
| 3 (in isoform 3) | Ubiquitination | - | 36.06 | 21890473 | |
| 3 (in isoform 2) | Ubiquitination | - | 36.06 | 21890473 | |
| 3 (in isoform 1) | Ubiquitination | - | 36.06 | 21890473 | |
| 3 | Ubiquitination | -----MVKLFIGNLP -----CCEEEECCCC | 36.06 | 21890473 | |
| 3 | Sumoylation | -----MVKLFIGNLP -----CCEEEECCCC | 36.06 | - | |
| 3 | Sumoylation | -----MVKLFIGNLP -----CCEEEECCCC | 36.06 | - | |
| 25 | Phosphorylation | IRSLFEQYGKVLECD HHHHHHHHCCCEECE | 16.24 | 29496907 | |
| 27 | Ubiquitination | SLFEQYGKVLECDII HHHHHHCCCEECEEH | 38.42 | 23000965 | |
| 35 | Ubiquitination | VLECDIIKNYGFVHI CEECEEHHCCEEEEE | 44.44 | 21963094 | |
| 37 | Phosphorylation | ECDIIKNYGFVHIED ECEEHHCCEEEEECC | 13.62 | 25159151 | |
| 45 | 2-Hydroxyisobutyrylation | GFVHIEDKTAAEDAI EEEEECCCCHHHHHH | 27.55 | - | |
| 45 | Ubiquitination | GFVHIEDKTAAEDAI EEEEECCCCHHHHHH | 27.55 | 21963094 | |
| 59 | Acetylation | IRNLHHYKLHGVNIN HHHHHHHEECCEEEE | 29.65 | - | |
| 59 | Ubiquitination | IRNLHHYKLHGVNIN HHHHHHHEECCEEEE | 29.65 | 21963094 | |
| 71 | Sumoylation | NINVEASKNKSKTST EEEEEECCCCCCCCC | 75.37 | - | |
| 71 | Ubiquitination | NINVEASKNKSKTST EEEEEECCCCCCCCC | 75.37 | - | |
| 71 | Sumoylation | NINVEASKNKSKTST EEEEEECCCCCCCCC | 75.37 | - | |
| 76 | Phosphorylation | ASKNKSKTSTKLHVG ECCCCCCCCCEEEEC | 49.04 | 25690035 | |
| 77 | Phosphorylation | SKNKSKTSTKLHVGN CCCCCCCCCEEEECC | 27.55 | 25690035 | |
| 78 | Phosphorylation | KNKSKTSTKLHVGNI CCCCCCCCEEEECCC | 42.74 | 25690035 | |
| 79 | Sumoylation | NKSKTSTKLHVGNIS CCCCCCCEEEECCCC | 36.04 | 28112733 | |
| 79 | Acetylation | NKSKTSTKLHVGNIS CCCCCCCEEEECCCC | 36.04 | 25953088 | |
| 79 | Ubiquitination | NKSKTSTKLHVGNIS CCCCCCCEEEECCCC | 36.04 | 29967540 | |
| 86 | Phosphorylation | KLHVGNISPTCTNKE EEEECCCCCCCCCHH | 20.39 | 29255136 | |
| 88 | Phosphorylation | HVGNISPTCTNKELR EECCCCCCCCCHHHH | 25.77 | 29255136 | |
| 90 | Phosphorylation | GNISPTCTNKELRAK CCCCCCCCCHHHHHH | 52.37 | 29255136 | |
| 92 | Ubiquitination | ISPTCTNKELRAKFE CCCCCCCHHHHHHHH | 39.72 | 23000965 | |
| 92 | Sumoylation | ISPTCTNKELRAKFE CCCCCCCHHHHHHHH | 39.72 | 28112733 | |
| 92 | Sumoylation | ISPTCTNKELRAKFE CCCCCCCHHHHHHHH | 39.72 | - | |
| 92 | Acetylation | ISPTCTNKELRAKFE CCCCCCCHHHHHHHH | 39.72 | 25953088 | |
| 97 | Sumoylation | TNKELRAKFEEYGPV CCHHHHHHHHHHCCE | 47.04 | - | |
| 97 | Sumoylation | TNKELRAKFEEYGPV CCHHHHHHHHHHCCE | 47.04 | - | |
| 97 | Acetylation | TNKELRAKFEEYGPV CCHHHHHHHHHHCCE | 47.04 | 26051181 | |
| 97 | Ubiquitination | TNKELRAKFEEYGPV CCHHHHHHHHHHCCE | 47.04 | 23000965 | |
| 101 | Phosphorylation | LRAKFEEYGPVIECD HHHHHHHHCCEEEEE | 21.38 | 29496907 | |
| 111 | Ubiquitination | VIECDIVKDYAFVHM EEEEEEEECEEEEEH | 45.41 | 29967540 | |
| 113 | Phosphorylation | ECDIVKDYAFVHMER EEEEEECEEEEEHHH | 9.02 | 28796482 | |
| 129 | Methylation | EDAVEAIRGLDNTEF HHHHHHHHCCCCCCC | 46.82 | - | |
| 139 | Ubiquitination | DNTEFQGKRMHVQLS CCCCCCCEEEEEEEE | 35.45 | 27667366 | |
| 139 | 2-Hydroxyisobutyrylation | DNTEFQGKRMHVQLS CCCCCCCEEEEEEEE | 35.45 | - | |
| 139 | Acetylation | DNTEFQGKRMHVQLS CCCCCCCEEEEEEEE | 35.45 | 12431749 | |
| 145 (in isoform 2) | Methylation | - | 6.16 | - | |
| 146 | Phosphorylation | KRMHVQLSTSRLRTA EEEEEEEECCCCCCC | 13.77 | 28857561 | |
| 147 | Phosphorylation | RMHVQLSTSRLRTAP EEEEEEECCCCCCCC | 26.85 | 28555341 | |
| 152 | Phosphorylation | LSTSRLRTAPGMGDQ EECCCCCCCCCCCCC | 41.62 | 21406692 | |
| 160 (in isoform 2) | Ubiquitination | - | 35.25 | - | |
| 160 | Phosphorylation | APGMGDQSGCYRCGK CCCCCCCCCCCCCCC | 35.25 | 21406692 | |
| 163 | Phosphorylation | MGDQSGCYRCGKEGH CCCCCCCCCCCCCCC | 16.68 | 21406692 | |
| 173 | Sumoylation | GKEGHWSKECPIDRS CCCCCCCCCCCCCCC | 59.13 | - | |
| 173 | Ubiquitination | GKEGHWSKECPIDRS CCCCCCCCCCCCCCC | 59.13 | 22505724 | |
| 173 | Sumoylation | GKEGHWSKECPIDRS CCCCCCCCCCCCCCC | 59.13 | - | |
| 173 | Acetylation | GKEGHWSKECPIDRS CCCCCCCCCCCCCCC | 59.13 | 26051181 | |
| 187 | Phosphorylation | SGRVADLTEQYNEQY CCCCCHHHHHHHHHH | 22.91 | 27642862 | |
| 190 | Phosphorylation | VADLTEQYNEQYGAV CCHHHHHHHHHHCCC | 17.90 | 21945579 | |
| 194 | Phosphorylation | TEQYNEQYGAVRTPY HHHHHHHHCCCCCCE | 10.81 | 21945579 | |
| 201 | Phosphorylation | YGAVRTPYTMSYGDS HCCCCCCEECCCCCC | 17.92 | 20090780 | |
| 205 | Phosphorylation | RTPYTMSYGDSLYYN CCCEECCCCCCCCCC | 17.71 | - | |
| 208 | Phosphorylation | YTMSYGDSLYYNNAY EECCCCCCCCCCCCH | 17.57 | - | |
| 210 | Phosphorylation | MSYGDSLYYNNAYGA CCCCCCCCCCCCHHH | 14.22 | 20090780 | |
| 211 | Phosphorylation | SYGDSLYYNNAYGAL CCCCCCCCCCCHHHH | 13.77 | 27642862 | |
| 215 | Phosphorylation | SLYYNNAYGALDAYY CCCCCCCHHHHHHHH | 12.68 | - | |
| 221 | Phosphorylation | AYGALDAYYKRCRAA CHHHHHHHHHHHHHH | 14.80 | - | |
| 222 | Phosphorylation | YGALDAYYKRCRAAR HHHHHHHHHHHHHHH | 8.15 | - | |
| 223 | Ubiquitination | GALDAYYKRCRAARS HHHHHHHHHHHHHHC | 32.14 | 21963094 | |
| 223 | Sumoylation | GALDAYYKRCRAARS HHHHHHHHHHHHHHC | 32.14 | - | |
| 223 | Acetylation | GALDAYYKRCRAARS HHHHHHHHHHHHHHC | 32.14 | 26051181 | |
| 272 | Phosphorylation | TSTSLDPYDRHLLPT HCCCCCCCCCCCCCC | 25.85 | 25884760 | |
| 279 | O-linked_Glycosylation | YDRHLLPTSGAAATA CCCCCCCCCHHHHHH | 39.50 | 31373491 | |
| 280 | O-linked_Glycosylation | DRHLLPTSGAAATAA CCCCCCCCHHHHHHH | 25.21 | 31373491 | |
| 285 | Phosphorylation | PTSGAAATAAAAAAA CCCHHHHHHHHHHHH | 16.47 | 26434776 | |
| 285 | O-linked_Glycosylation | PTSGAAATAAAAAAA CCCHHHHHHHHHHHH | 16.47 | 31373491 | |
| 297 | Phosphorylation | AAAAAAVTAASTSYY HHHHHHHHHHHHCCC | 16.27 | 27174698 | |
| 297 | O-linked_Glycosylation | AAAAAAVTAASTSYY HHHHHHHHHHHHCCC | 16.27 | 31373491 | |
| 300 | O-linked_Glycosylation | AAAVTAASTSYYGRD HHHHHHHHHCCCCCC | 18.54 | 31373491 | |
| 300 | Phosphorylation | AAAVTAASTSYYGRD HHHHHHHHHCCCCCC | 18.54 | 27174698 | |
| 301 | O-linked_Glycosylation | AAVTAASTSYYGRDR HHHHHHHHCCCCCCC | 18.93 | 31373491 | |
| 301 | Phosphorylation | AAVTAASTSYYGRDR HHHHHHHHCCCCCCC | 18.93 | 27174698 | |
| 302 | O-linked_Glycosylation | AVTAASTSYYGRDRS HHHHHHHCCCCCCCC | 17.54 | 31373491 | |
| 302 | Phosphorylation | AVTAASTSYYGRDRS HHHHHHHCCCCCCCC | 17.54 | 27174698 | |
| 303 | Phosphorylation | VTAASTSYYGRDRSP HHHHHHCCCCCCCCC | 15.27 | 20090780 | |
| 304 | Phosphorylation | TAASTSYYGRDRSPL HHHHHCCCCCCCCCC | 12.88 | 27174698 | |
| 309 | Phosphorylation | SYYGRDRSPLRRATA CCCCCCCCCCCCCCC | 32.35 | 30266825 | |
| 315 | Phosphorylation | RSPLRRATAPVPTVG CCCCCCCCCCCCCCC | 29.68 | 28796482 | |
| 320 | Phosphorylation | RATAPVPTVGEGYGY CCCCCCCCCCCCCCC | 41.18 | 28796482 | |
| 325 | Phosphorylation | VPTVGEGYGYGHESE CCCCCCCCCCCCHHH | 11.67 | 28796482 | |
| 327 | Phosphorylation | TVGEGYGYGHESELS CCCCCCCCCCHHHHH | 13.56 | 28796482 | |
| 331 | O-linked_Glycosylation | GYGYGHESELSQASA CCCCCCHHHHHHHHH | 37.86 | 31373491 | |
| 331 | Phosphorylation | GYGYGHESELSQASA CCCCCCHHHHHHHHH | 37.86 | 28796482 | |
| 334 | Phosphorylation | YGHESELSQASAAAR CCCHHHHHHHHHHHH | 21.46 | 25849741 | |
| 337 | Phosphorylation | ESELSQASAAARNSL HHHHHHHHHHHHHHH | 15.71 | 28796482 | |
| 343 | Phosphorylation | ASAAARNSLYDMARY HHHHHHHHHHHHHHH | 23.82 | 28796482 | |
| 345 | Phosphorylation | AAARNSLYDMARYER HHHHHHHHHHHHHHH | 11.95 | 25159151 | |
| 350 | Phosphorylation | SLYDMARYEREQYAD HHHHHHHHHHHHHHH | 15.14 | - | |
| 355 | Phosphorylation | ARYEREQYADRARYS HHHHHHHHHHHHHHH | 13.01 | - | |
| 358 | Methylation | EREQYADRARYSAF- HHHHHHHHHHHHCC- | 16.88 | 83108829 | |
| 361 | Phosphorylation | QYADRARYSAF---- HHHHHHHHHCC---- | 11.90 | 20736484 | |
| 362 | Phosphorylation | YADRARYSAF----- HHHHHHHHCC----- | 20.04 | 22210691 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 309 | S | Phosphorylation | Kinase | SRPK1 | Q96SB4 | PSP |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBM4_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Cell stress modulates the function of splicing regulatory proteinRBM4 in translation control."; Lin J.C., Hsu M., Tarn W.Y.; Proc. Natl. Acad. Sci. U.S.A. 104:2235-2240(2007). Cited for: FUNCTION, INTERACTION WITH EIF4A1 AND EIF4G1, PHOSPHORYLATION ATSER-309, ASSOCIATION WITH IRES OF MRNAS, SUBCELLULAR LOCATION, ANDMUTAGENESIS OF SER-309. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-190 AND TYR-194, ANDMASS SPECTROMETRY. | |